Figure 4B showed correlation between LYPD3 expression and clinicopathological characteristics of melanoma patients, indicating that LYPD3 was positively correlated with several melanoma classifications, namely, T classification for TNM staging (p < 0.01), and Breslow depth (p < 0.001). The gene discussed is LYPD3; the disease is melanoma.